UCSF

ZINC03977779

Substance Information

In ZINC since Heavy atoms Benign functionality
October 28th, 2005 29 Yes

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.71 4.52 -9.24 3 7 0 113 410.507 3

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.10e+00 g/l DrugBank-experimental
M.P 230-232 C Indofine Natural Products
M.P 282-232 °C Indofine Natural Products
UniProt Database Links ADCY3_RAT; ADCY9_CHICK; ADCY9_HUMAN; ADCY9_MOUSE; CCNL1_RAT; CITE1_MOUSE; CORT_HUMAN; DUOX1_CANFA; DUOX1_HUMAN; DUOX2_HUMAN; DUOX2_PIG; DUOX2_RAT; EDF1_BOVIN; EDF1_HUMAN; EDF1_MOUSE; EDF1_RAT; F132B_MOUSE; FCOR_MOUSE; FOXO1_MOUSE; GDNF_MOUSE; GP126_DANRE ChEBI
Therapy adenylate cyclase activator, antiglaucoma SMDC Pharmakon
therap adenylate cyclase activator, antiglaucoma, hypotensive, vasodilator MicroSource Spectrum
Target cAMP Selleck Chemicals
SOLUBILITY DMSO: 5 mg/mL stable at least 6 months at room temperature Indofine Natural Products
Patent Database Links EP1074253; EP1552824; EP1568770; EP1591441; EP1659172; EP1797876; EP1978090; US2002045579; US2007190103; US2007232523; US2007232698; US2007248690; WO2006116301; WO2007091790; WO2007102162; WO2007108727; WO2007109884; WO2007123699; WO2007123872; WO20071337 ChEBI
APPEARANCE Off-white Indofine Natural Products
SOLUBILITY Soluble in Chloroform,; benzene, methanol,dichloromethane Indofine Natural Products
PUBCHEM_PATENT_ID US4902696; US5846992 IBM Patent Data
APPEARANCE White crystalline powder Indofine Natural Products

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ADCY1-1-E Brain Adenylate Cyclase 1 (cluster #1 Of 1), Eukaryotic Eukaryotes 41 0.36 Binding ≤ 10μM
GTR1-1-E Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 (cluster #1 Of 1), Eukaryotic Eukaryotes 5000 0.26 Binding ≤ 10μM
ADCY1-2-E Brain Adenylate Cyclase 1 (cluster #2 Of 2), Eukaryotic Eukaryotes 500 0.30 Functional ≤ 10μM
ADCY2-1-E Adenylate Cyclase Type II (cluster #1 Of 1), Eukaryotic Eukaryotes 2000 0.28 Functional ≤ 10μM
Z100499-2-O SARS Coronavirus (cluster #2 Of 2), Other Other 7500 0.25 Functional ≤ 10μM
Z50587-5-O Homo Sapiens (cluster #5 Of 9), Other Other 240 0.32 Functional ≤ 10μM
Z50597-11-O Rattus Norvegicus (cluster #11 Of 12), Other Other 240 0.32 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
ADCY1_BOVIN P19754 Adenylate Cyclase Type I, Bovin 29 0.36 Binding ≤ 1μM
ADCY1_HUMAN Q08828 Brain Adenylate Cyclase 1, Human 150 0.33 Binding ≤ 1μM
ADCY1_BOVIN P19754 Adenylate Cyclase Type I, Bovin 29 0.36 Binding ≤ 10μM
ADCY1_HUMAN Q08828 Brain Adenylate Cyclase 1, Human 150 0.33 Binding ≤ 10μM
GTR1_HUMAN P11166 Glucose Transporter, Human 5000 0.26 Binding ≤ 10μM
ADCY2_RAT P26769 Adenylate Cyclase Type II, Rat 2000 0.28 Functional ≤ 10μM
ADCY1_HUMAN Q08828 Brain Adenylate Cyclase 1, Human 500 0.30 Functional ≤ 10μM
Z50587 Z50587 Homo Sapiens 240 0.32 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 240 0.32 Functional ≤ 10μM
Z100499 Z100499 SARS Coronavirus 7500 0.25 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Adenylate cyclase activating pathway
Adenylate cyclase inhibitory pathway
CREB phosphorylation through the activation of Adenylate Cyclase
G alpha (i) signalling events
G alpha (s) signalling events
G alpha (z) signalling events
Glucagon signaling in metabolic regulation
Glucose transport
PKA activation
PKA activation in glucagon signalling
Regulation of insulin secretion
Vasopressin regulates renal water homeostasis via Aquaporins
Vitamin C (ascorbate) metabolism

Analogs ( Draw Identity 99% 90% 80% 70% )